Mode
Text Size
Log in / Sign up

dexrazoxane

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of dexrazoxane

10 trials tracked of dexrazoxane: 2 in phase 3 or 4 and 2 with published results. The most-cited published study has 238 citations.

10Trials tracked
2Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 3 2 Phase 2 5 Phase 1 3
  1. Phase 3 05-001: Treatment of Acute Lymphoblastic Leukemia in Children Completed · 238 cited
  2. Phase 3 Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma Completed · 98 cited
  3. Phase 2 Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma Completed
  4. Phase 2 A Phase I/II Study of KDX-0811(Dexrazoxane) in the Treatment of Accidental Extravasation of Anthracycline Anti-cancer Agents Completed
  5. Phase 2 Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Completed
  6. Phase 2 Chemotherapy Combined With Radiation Therapy for Newly Diagnosed CNS AT/RT Completed
Show 4 more trials
  1. Phase 2 Chemoimmunotherapy With Epratuzumab in Relapsed Acute Lymphoblastic Leukemia (ALL) Completed
  2. Phase 1 Prevention of Heart Failure Induced by Doxorubicin With Early Administration of Dexrazoxane Completed
  3. Phase 1 Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma Completed
  4. Phase 1 Crizotinib and Combination Chemotherapy in Treating Younger Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma Completed

Showing the 10 most-cited and recently-updated of 10 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.